Issue |
J Extra Corpor Technol
Volume 16, Number 2, June 1984
|
|
---|---|---|
Page(s) | 55 - 57 | |
DOI | https://doi.org/10.1051/ject/198416255 | |
Published online | 13 September 2023 |
Original Article
Hetastarch as a Clear Prime for Cardiopulmonary Bypass
1 West Jefferson General Hospital, Marrero, Louisiana
2 Presbyterian-University of Pennsylvania Medical Center (Dr. Parr), Philadelphia, Pennsylvania
3 The Milton S. Hershey Medical Center (Dennis Williams), The Pennsylvania State University, Hershey, Pennsylvania
* Direct communications to: David A. Palanzo. C.C.P., Medical Specialties Building. 4520 Wichers Drive, Suite 203. Marrero, LA 70072.
Hydroxyethyl starch, an artificial plasma expander, was investigated for use as a colloidal pump prime for cardiopulmonary bypass. A 3% hetastarch solution was compared with a 4% albumin solution in eighty-four patients undergoing myocardial revascularization. There was no statistical difference in patient population when compared by age, weight, body surface area, bypass time and aortic cross-clamp time. The postbypass platelet counts were lower in those patients receiving the hetastarch prime, but they were sufficient to maintain normal hemostasis. There were no differences in chest tube drainage, blood products used, plasma hemoglobin, or fibrinogen levels. The albumin prime costs nearly three times as much per patient as the hetastarch prime.
© 1984 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.